Review
Immunology
Jiansong Chen, Yiguo Shen, Xiaobo Shao, Weiliang Wu
Summary: Spinal cord injury (SCI) and spinal cord tumor cause significant damage to the spinal cord, leading to multiple impairments and high morbidity and mortality. The treatment options for these conditions are limited and the underlying molecular mechanisms remain unclear. In the review, the role of inflammasomes in SCI and spinal cord tumors is highlighted, and targeting inflammasomes is suggested as a potential therapeutic strategy.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Cell Biology
Haoyu Wang, Haifan Wang, Heng Huang, Zhigang Qu, Dong Ma, Xiaoqian Dang, Quanyu Dong
Summary: Melatonin inhibits the activation of the NLRP3 inflammasome through the stimulation of the Nrf2/ARE pathway, which suppresses neuroinflammation, reduces mitochondrial dysfunction, and improves the recovery of nerve function after spinal cord injury.
Review
Cell Biology
Alireza Shadab, Mohamad Mahjoor, Mohammad Abbasi-Kolli, Hamed Afkhami, Parisa Moeinian, Amir-Reza Safdarian
Summary: This article investigates the activation of the NLRP3 inflammasome and its effects on the crosstalk between different organs, as well as the role of chronic inflammation in cancer pathogenesis. The research on the NLRP3 inflammasome may represent an innovative therapeutic target to reverse the malignancy consequences of inflammation.
CELL COMMUNICATION AND SIGNALING
(2023)
Article
Cell Biology
Irvan Alfian, Amlan Chakraborty, Hannah E. J. Yong, Sheetal Saini, Ricky W. K. Lau, Bill Kalionis, Evdokia Dimitriadis, Nadia Alfaidy, Sharon D. Ricardo, Chrishan S. Samuel, Padma Murthi
Summary: This study found that the gene expression of placental inflammasomes is different in FGR pregnancies, which may contribute to abnormal trophoblast function.
Review
Clinical Neurology
Sen Lin, Xifan Mei
Summary: Inflammasomes are crucial intracellular complexes involved in inflammatory immune responses, with potential implications in neuroinflammation diseases therapy, although their role in SCI development and progression remains controversial.
EUROPEAN NEUROLOGY
(2021)
Review
Cell Biology
Lei Xie, Hang Wu, Xiaohong Huang, Tengbo Yu
Summary: Spinal cord injury (SCI) is a sudden disruption to the spinal neural tissue, causing loss of motor control and sensory function. Melatonin, a hormone with antioxidant properties, has been shown to have neuroprotective effects in SCI, reducing inflammation, oxidative stress, and cell death. This review highlights the potential applications of melatonin in SCI rehabilitation, including its synergistic effects with drugs, rehabilitation training, and stem cell therapy.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2023)
Article
Immunology
Yue Guo, Peng Zhang, Haosen Zhao, Chang Xu, Sen Lin, Xifan Mei, He Tian
Summary: In this study, melatonin was found to promote the beneficial polarization of microglia from pro-inflammatory to anti-inflammation, decrease ROS activity, and restore mitochondrial metabolism. Melatonin may have therapeutic potential for neuroinflammation-related neurological disorders, such as spinal cord injury.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2023)
Article
Physiology
Yu Huang, Jin Lin, Xuanwei Chen, Jianhua Lin
Summary: This study evaluated the role of Pannexin-1 in the development of spinal cord injury, revealing that Panx1 exacerbates cell apoptosis and worsens secondary damage.
FRONTIERS IN PHYSIOLOGY
(2021)
Article
Neurosciences
Houling Zhao, Xi Wang, Shuheng Liu, Qingguo Zhang
Summary: Paeonol plays a role in anti-inflammation, anti-oxidation, and neuroprotection in the progression of spinal cord injury (SCI). It alleviates SCI by regulating NLRP3 inflammasomes and pyroptosis, and promoting the polarization of BV-2 cells.
Article
Medicine, General & Internal
Yu Ming Chuan, Yu Wang, Xu Jin, Shi Qing Ming, Wan Wen Bing, Wu Kai, Chen Xiang, Peng Kun
Summary: This study evaluates the protective effect of tabersonine against spinal cord injury, and the results suggest that it improves neurological and motor functions, reduces inflammation, and inhibits cell apoptosis.
ARCHIVES OF MEDICAL SCIENCE
(2023)
Article
Neurosciences
Narjes Shahsavani, Arsalan Alizadeh, Hardeep Kataria, Soheila Karimi-Abdolrezaee
Summary: Nrg-1131 provides early neuroprotection in SCI by reducing oxidative stress, lipid peroxidation, necrosis, and apoptosis. Mechanistically, it protects neurons from cell death by modulating mitochondrial-associated apoptotic cascades, MAP kinase, and AKT signaling pathways.
EXPERIMENTAL NEUROLOGY
(2021)
Article
Immunology
Ran Zheng, Yang Ruan, Yiqun Yan, Zhihao Lin, Naijia Xue, Yaping Yan, Jun Tian, Xinzhen Yin, Jiali Pu, Baorong Zhang
Summary: The study shows that melatonin can effectively alleviate motor dysfunction in a Parkinson's disease model, and reduce neuroinflammation by negatively regulating NLRP3 inflammasome activation.
JOURNAL OF INFLAMMATION RESEARCH
(2021)
Article
Cell Biology
Maryam Baazm, Victoria Behrens, Cordian Beyer, Omid Nikoubashman, Adib Zendedel
Summary: Omega-3 polyunsaturated fatty acids play a neuroprotective role by targeting the NLRP3 inflammasome and reducing inflammation after spinal cord injury (SCI). Treatment with PUFA n3 significantly improves locomotor recovery and suppresses the upregulation of inflammasome components induced by SCI.
Article
Medicine, Research & Experimental
Hua Hu, Xiaofei Jian
Summary: A rat model of ASCI was treated with plantamajoside to study the effects on apoptotic factors, showing that PMS may be a potential candidate for ASCI therapy by inhibiting apoptosis and improving spinal cord morphology.
EXPERIMENTAL AND THERAPEUTIC MEDICINE
(2021)
Review
Biochemistry & Molecular Biology
Salih Atalah Alenezi, Raheela Khan, Lindsay Snell, Shaimaa Aboeldalyl, Saad Amer
Summary: Inflammasomes have been found to play a role in chronic inflammatory disorders, including diabetes and obesity. This meta-analysis aimed to investigate the involvement of the NLRP3 inflammasome in obesity and PCOS. The analysis included studies on NLRP3 and its related components in adipose tissue and blood of obese individuals, as well as studies on NLRP3 in PCOS women and animal models. The results suggest that obesity and PCOS are associated with upregulated expression of NLRP3 inflammasome components, but further research is needed to confirm these findings and understand the role of NLRP3 in these conditions.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)